Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Zeneo Methotrexate vs Conventional Syringe
NCT03103334Phase 1Completed
- Sponsor
- Crossject
- Start
- Jun 2014
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, open-label trial of methotrexate in rheumatoid arthritis (RA) (4 arms), sponsored by Crossject. Primary endpoints: Maximum observed plasma concentration and Area under the plasma concentration versus time curve from time zero to last quantifiable concentration. Started Jun 2014; status: completed.
02
Drugs
methotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03103334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03103334.